MiMedx Postpones Release of its Fourth Quarter and Fiscal Year 2017 Financial Results

February 20, 2018

Responsive image

MARIETTA, Ga., Feb. 20, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that it will postpone the release of its financial results, as well as the filing of its Form 10-K, for the year…

Category: Precious Metals